Prevention of Unexplained Recurrent Spontaneous Abortion Using Intravenous Immunoglobulin: A Prospective, Randomized, Double‐Blinded, Placebo‐Controlled Trial

医学 流产 安慰剂 怀孕 妊娠期 随机化 随机对照试验 产科 妇科 儿科 外科 病理 遗传学 生物 替代医学
作者
Mary D. Stephenson,Kim Dreher,Edwina Houlihan,Vivian Wu
出处
期刊:American Journal of Reproductive Immunology [Wiley]
卷期号:39 (2): 82-88 被引量:114
标识
DOI:10.1111/j.1600-0897.1998.tb00339.x
摘要

The efficacy of intravenous immunoglobulin (IVIG) for treatment of unexplained recurrent spontaneous abortion was assessed in a prospective, randomized, double-blinded, and placebo-controlled study.The study took place in a provincial recurrent pregnancy loss clinic, located in a tertiary/quaternary care academic center. The study subjects were women with a history of two or more documented consecutive spontaneous pregnancy losses under 20 weeks of gestation, excluding any associated with aneuploidy by karyotype analysis, and with no evidence of genetic, endocrine, infectious, anatomic, or autoimmune factors associated with a history of recurrent spontaneous abortion. The subjects were randomized to receive either intravenous immunoglobulin (Gamimune N) as treatment or normal saline as placebo. Randomization was stratified for primary, secondary, and unclassified unexplained recurrent spontaneous abortion. Success was defined as an ongoing pregnancy beyond 20 weeks of gestation.Sixty-two subjects enrolled in the trial. There were 37 index pregnancies and 6 cross-over pregnancies. There was no clinically significant difference between the treatment arm and the placebo arm in terms of subsequent pregnancy success. There seemed to be a higher success rate with the stratified analysis of couples with secondary unexplained recurrent spontaneous abortion, but the trial did not have sufficient power to confirm this.Based on this trial and three similar trials in the literature, a multicentered trial is needed to determine conclusively whether IVIG is effective in the treatment of unexplained recurrent spontaneous abortion.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风趣青槐完成签到,获得积分10
刚刚
刘洪均完成签到,获得积分10
刚刚
1秒前
冷艳芯发布了新的文献求助10
3秒前
我爱科研完成签到,获得积分10
5秒前
6秒前
碰碰完成签到,获得积分10
6秒前
6秒前
大个应助Aaron采纳,获得10
6秒前
Carrot完成签到,获得积分10
7秒前
英俊的铭应助宫冷雁采纳,获得10
7秒前
汉堡包应助zzy采纳,获得30
9秒前
9秒前
路灯下的小伙完成签到,获得积分10
9秒前
ning发布了新的文献求助10
9秒前
欢呼吐司发布了新的文献求助20
12秒前
十一发布了新的文献求助10
12秒前
大模型应助shinn采纳,获得50
12秒前
13秒前
15秒前
onlyan发布了新的文献求助10
16秒前
17秒前
18秒前
18秒前
20秒前
20秒前
ning完成签到,获得积分10
20秒前
万能图书馆应助西瓜籽采纳,获得10
21秒前
22秒前
22秒前
22秒前
宫冷雁发布了新的文献求助10
23秒前
sqz完成签到,获得积分10
23秒前
24秒前
24秒前
25秒前
25秒前
Mickey完成签到,获得积分10
25秒前
慕青应助enen采纳,获得30
25秒前
九卫发布了新的文献求助10
25秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975250
求助须知:如何正确求助?哪些是违规求助? 3519625
关于积分的说明 11199055
捐赠科研通 3255962
什么是DOI,文献DOI怎么找? 1798001
邀请新用户注册赠送积分活动 877358
科研通“疑难数据库(出版商)”最低求助积分说明 806298